Glycoprotein acetyls: A game-changing biomarker for cardiovascular risk in rheumatoid arthritis patients
Secukinumab 150 mg effective in reducing NSAID dependence for ankylosing spondylitis: ASTRUM study breakthrough
Tocilizumab offers hope for rheumatoid arthritis with interstitial lung disease, but caution advised against respiratory infections
Early clinical trial results show promise of antibody treatment for patients with systemic lupus erythematosus or rheumatoid arthritis
